PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34298726-9 2021 Inhibition studies indicated that FAK is not involved in doxorubicin efflux and chemoresistance, whereas PYK2 inhibition abrogated both VLA-4-induced doxorubicin efflux and chemoresistance. Doxorubicin 150-161 protein tyrosine kinase 2 beta Homo sapiens 105-109 31707337-12 2020 Combination treatment with DOX and Mag significantly inhibited the activation of phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling, and promoted p38 mitogen-activated protein kinase (MAPK) pathway. Doxorubicin 27-30 protein tyrosine kinase 2 beta Homo sapiens 111-127 32562081-6 2021 RESULTS: We observed that MSM itself induces apoptosis in EC cell lines, and pre-treatment with MSM for 24 h increases the sensitivity of EC cells to DOX-induced apoptosis and DNA damage and that effect might be regulated by p42/44 (Erk1/2) MAPK and Akt (protein kinase B). Doxorubicin 150-153 protein tyrosine kinase 2 beta Homo sapiens 255-271 31043590-7 2019 Finally, our findings showed that Matrigel/beta1 interaction enhanced doxorubicin efflux and chemoresistance by activating the FAK-related proline-rich tyrosine kinase 2 (PYK2) as both PYK2 inhibitor and siRNA diminished the effect of Matrigel. Doxorubicin 70-81 protein tyrosine kinase 2 beta Homo sapiens 139-169 31043590-7 2019 Finally, our findings showed that Matrigel/beta1 interaction enhanced doxorubicin efflux and chemoresistance by activating the FAK-related proline-rich tyrosine kinase 2 (PYK2) as both PYK2 inhibitor and siRNA diminished the effect of Matrigel. Doxorubicin 70-81 protein tyrosine kinase 2 beta Homo sapiens 171-175 30020827-4 2018 In TRPM2-depleted cells, phosphorylation and expression of Pyk2 and cAMP-responsive element-binding protein (CREB), a downstream target, were significantly reduced after application of the chemotherapeutic agent doxorubicin. Doxorubicin 212-223 protein tyrosine kinase 2 beta Homo sapiens 59-63 30351976-8 2018 Meanwhile, DOX induced activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt/PKB) and mammalian target of rapamycin (mTOR) pathways that cross talked with AMPK. Doxorubicin 11-14 protein tyrosine kinase 2 beta Homo sapiens 74-90 25796439-0 2015 Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells. Doxorubicin 71-82 protein tyrosine kinase 2 beta Homo sapiens 27-31 25796439-4 2015 MCF-7/Dox cells expressed constitutively active forms of the tyrosine kinases: focal adhesion kinase (FAK-Y397) and protein tyrosine kinase 2 beta (Pyk2- Y579/580) compared with parental MCF-7 cells. Doxorubicin 6-9 protein tyrosine kinase 2 beta Homo sapiens 148-152 32038792-5 2008 Furthermore, the treatment of cells with doxorubicin, DNA-damage inducing agent, leads to PKB phosphorylation on Ser473 in control MEF cells while there is no response in DNA-PK knockout MEF cells. Doxorubicin 41-52 protein tyrosine kinase 2 beta Homo sapiens 90-93